Related Experiment Video
Updated: Nov 5, 2025

06:18
Author Spotlight: Segmentation and VR for Advanced Neurovascular Interventions
Published on: April 5, 2024
1.3K
Virtual reality distraction during uterovaginal brachytherapy applicators' removal: A pilot comparative study
Romain Varnier1, Odile Brière2, Thomas Brouillard2
1Department of Radiation Oncology, Centre Léon Bérard, Lyon, France.
Brachytherapy
|May 18, 2021
Summary
Virtual reality (VR) distraction effectively reduced anxiety and pain during cervical brachytherapy applicator removal, offering a feasible alternative to nitrous oxide (N2O) conscious sedation.
Area of Science:
- Oncology
- Radiotherapy
- Pain Management
Background:
- Cervical brachytherapy requires applicator removal, which can cause patient anxiety and pain.
- Current methods like nitrous oxide (N2O) conscious sedation have limitations.
Purpose of the Study:
- To evaluate virtual reality (VR) distraction as an alternative to N2O for reducing anxiety and pain during uterovaginal brachytherapy applicator removal.
- To assess the feasibility and patient experience with VR during this procedure.
Main Methods:
- A prospective study involving 35 patients undergoing cervical brachytherapy.
- Patients were randomized to receive either N2O conscious sedation or VR distraction.
- Anxiety and pain were measured using STAI-E and Visual Analogical Scales (VAS).
Main Results:
- The VR group showed comparable or lower anxiety and pain scores compared to the N2O group.
- While preparation time was longer for VR, the removal duration was similar.
- Four patients in the VR group reported mild side effects like nausea or dizziness.
Conclusions:
- Virtual reality distraction is a feasible and acceptable alternative to N2O for managing pain and anxiety during brachytherapy applicator removal.
- Further randomized trials are necessary to confirm VR's efficacy and identify optimal patient candidates.

